Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    9109757 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept
Condition: Retinal Vein Occlusion
2 Completed Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Condition: Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Interventions: Drug: 0.5mg Ranibizumab;   Procedure: Targeted Pan Retinal Photocoagulation
3 Completed Central Vein Occlusion Study (CVOS)
Conditions: Retinal Vein Occlusion;   Retinal Diseases
Intervention: Procedure: Photocoagulation Therapy

Indicates status has not been verified in more than two years